Inviting ecosystems into the exposome framework

[French medical studies: Educational reforms since 2018]

Clinical Images: Sarcoidosis revealed by recurrent dactylitis

Excess of infection with SARS-CoV-2 during the first versus second wave of the COVID-19 pandemic among patients with long COVID

[Ambitions and main conclusions of the conference "Global health, local decisions" organized by the Digital Health Network]

CAR T-cell therapy in autoimmune diseases: where are we and where are we going?

Screening for transthyretin amyloid cardiomyopathy in patients with musculoskeletal symptoms: Red flags in the rheumatology/orthopedics practice setting

[Using the social responsibility strategy to overhaul the healthcare system]

[Three years of reform of the first year of health studies and now?]

What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?

Mind-body practices in chronic inflammatory arthritis

Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort

Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis

Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat

A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic

The history of lupus throughout the ages

Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study

Systemic lupus pregnancies are characterized by an intrinsic pro-inflammatory monocyte transcriptome, driven by an aberrant miRNA signature

Development and validation of LUPIN: a patient-centred self-administered tool to assess disease activity and patient-reported outcomes in systemic lupus erythematosus

French protocol for the diagnosis and management of systemic lupus erythematosus

Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus

Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation study

Difficulties and Psychological Impact of the SARS-CoV-2 Pandemic in Patients with Systemic Lupus Erythematosus: A Nationwide Patient Association Study

Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's disease

Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome

Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approach

Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients

Variability of Primary Sjögren's Syndrome Is Driven by Interferon-α and Interferon-α Blood Levels Are Associated With the Class II HLA-DQ Locus

Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups

Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine

Systematic review: Methotrexate-A poorly understood and underused medication in inflammatory bowel disease

Methotrexate also improves rheumatoid arthritis through correction of microbiota dysbiosis

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event

Acute myocarditis after switching between two adalimumab biosimilars

Tissue microbiota: A 'secondary-self', first target of autoimmunity?

Borrelia Infections Under B Cell-Depleting Therapies: A Systematic Review of Diagnostic Challenges and Outcomes With Special Focus on Neurological Forms

Borrelia Infections Under B Cell-Depleting Therapies: A Systematic Review of Diagnostic Challenges and Outcomes With Special Focus on Neurological Forms

A prospective survey on therapeutic inertia in psoriatic arthritis (OPTI'PsA)

Validity Evidence of a Screening Tool for Early Detection of Clinical Crisis-Related Anxiety Amongst Medical Students

Clinical spectrum and outcome of Takayasu's arteritis in children

Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study